What is the address of KINESITHERAPIE DEFERME & CO?

The registered office of KINESITHERAPIE DEFERME & CO is located at Esenplein(DE) 21 box 1, 8600 Diksmuide.

Is KINESITHERAPIE DEFERME & CO still active?

Yes. According to the CBE (16 September 2026) KINESITHERAPIE DEFERME & CO is active, legal situation “Normale toestand”, started on 27 April 1999.

Is KINESITHERAPIE DEFERME & CO registered on Peppol?

No, KINESITHERAPIE DEFERME & CO is currently not registered on the Peppol network.

What is the enterprise number of KINESITHERAPIE DEFERME & CO?

The enterprise number of KINESITHERAPIE DEFERME & CO is BE0465957217.

When was KINESITHERAPIE DEFERME & CO founded?

KINESITHERAPIE DEFERME & CO was founded on 27 April 1999.

Who are the directors of KINESITHERAPIE DEFERME & CO?

According to the 2025 annual accounts, the directors of KINESITHERAPIE DEFERME & CO are: Peter Tallieu, Pieter Deferme.

Is KINESITHERAPIE DEFERME & CO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 April 1999; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did KINESITHERAPIE DEFERME & CO make in 2025?

KINESITHERAPIE DEFERME & CO posted a profit after taxes of € 13,559 in financial year 2025.

What is the revenue of KINESITHERAPIE DEFERME & CO?

As a small company, KINESITHERAPIE DEFERME & CO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 21,001.

KINESITHERAPIE DEFERME & CO (Private Limited) - Diksmuide

Dossier KINESITHERAPIE DEFERME & CO, printed on 16 September 2026 from databakkes.be/en/0465957217/kinesitherapie-deferme-co. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

KINESITHERAPIE DEFERME & CO from Diksmuide, company number BE0465957217, closed financial year 2025 with a result of € 13,559 after tax. For that financial year KINESITHERAPIE DEFERME & CO recorded a gross margin of € 21,001 and equity of € 70,052. Compared with financial year 2024, the result moved from € 8,669 to € 13,559. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 21, 2026.

What it is worth Growing

€ 70,052

▲ 24% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 13,559

▲ 56% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 49,081

▼ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 63,607.

People and assets in 2025

Vehicles and equipment

€ 712

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 613

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 5,140

▲ 6% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 8,669 Gross margin 2022: € 8,669 First fiscal year in the series	€ 10,981 Gross margin 2023: € 10,981 ▲ 27% vs 2022 (€ 8,669) Favourable step	€ 14,294 Gross margin 2024: € 14,294 ▲ 30% vs 2023 (€ 10,981) Favourable step	€ 21,001 Gross margin 2025: € 21,001 ▲ 47% vs 2024 (€ 14,294) Favourable step	▲ 47%
Profit after taxes	€ 2,225 Profit after taxes 2022: € 2,225 First fiscal year in the series	€ 4,994 Profit after taxes 2023: € 4,994 ▲ 124% vs 2022 (€ 2,225) Favourable step	€ 8,669 Profit after taxes 2024: € 8,669 ▲ 74% vs 2023 (€ 4,994) Favourable step	€ 13,559 Profit after taxes 2025: € 13,559 ▲ 56% vs 2024 (€ 8,669) Favourable step	▲ 56%
Equity	€ 62,722 Equity 2022: € 62,722 First fiscal year in the series	€ 58,497 Equity 2023: € 58,497 ▼ 7% vs 2022 (€ 62,722) Unfavourable step	€ 56,494 Equity 2024: € 56,494 ▼ 3% vs 2023 (€ 58,497) Unfavourable step	€ 70,052 Equity 2025: € 70,052 ▲ 24% vs 2024 (€ 56,494) Favourable step	▲ 24%
Total debts	€ 531 Total debts 2022: € 531 First fiscal year in the series	€ 14,679 Total debts 2023: € 14,679 ▲ € 14,148 vs 2022 (€ 531) Unfavourable step	€ 16,099 Total debts 2024: € 16,099 ▲ 10% vs 2023 (€ 14,679) Unfavourable step	€ 5,753 Total debts 2025: € 5,753 ▼ 64% vs 2024 (€ 16,099) Favourable step	▼ 64%
Cash	€ 41,036 Cash 2022: € 41,036 First fiscal year in the series	€ 52,100 Cash 2023: € 52,100 ▲ 27% vs 2022 (€ 41,036) Favourable step	€ 52,556 Cash 2024: € 52,556 ▲ 1% vs 2023 (€ 52,100) Favourable step	€ 49,081 Cash 2025: € 49,081 ▼ 7% vs 2024 (€ 52,556) Unfavourable step	▼ 7%
Retained profit	€ 56,277 Retained profit 2022: € 56,277 First fiscal year in the series	€ 52,052 Retained profit 2023: € 52,052 ▼ 8% vs 2022 (€ 56,277) Unfavourable step	€ 50,048 Retained profit 2024: € 50,048 ▼ 4% vs 2023 (€ 52,052) Unfavourable step	€ 63,607 Retained profit 2025: € 63,607 ▲ 27% vs 2024 (€ 50,048) Favourable step	▲ 27%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 9,220 Dividend 2023: € 9,220 Unchanged (€ 0) Unchanged	€ 10,673 Dividend 2024: € 10,673 ▲ 16% vs 2023 (€ 9,220) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 10,673) Unchanged	▼ 100%
Balance sheet total	€ 63,253 Balance sheet total 2022: € 63,253 First fiscal year in the series	€ 73,176 Balance sheet total 2023: € 73,176 ▲ 16% vs 2022 (€ 63,253) Unchanged	€ 72,593 Balance sheet total 2024: € 72,593 ▼ 1% vs 2023 (€ 73,176) Unchanged	€ 75,805 Balance sheet total 2025: € 75,805 ▲ 4% vs 2024 (€ 72,593) Unchanged	▲ 4%

Key figures of KINESITHERAPIE DEFERME & CO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to KINESITHERAPIE DEFERME & CO?

What happened at KINESITHERAPIE DEFERME & CO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 21, 2026 New annual accounts for financial year 2025: profit of € 13,559 (▲ 56% vs 2024). Source: NBB ↗
Jul 1, 2016 New establishment in Diksmuide. KBO
Apr 27, 1999 Start of the company according to the CBE. KBO

In short

From € 2,225 profit in 2022 to € 13,559 profit in 2025.

Paid € 15,266 in corporate taxes since 2022.

Best year ever: 2025, with € 13,559 profit.

Paid out € 19,893 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at KINESITHERAPIE DEFERME & CO? We notify you, reason included.

Follow KINESITHERAPIE DEFERME & CO

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Peter Tallieu Pieter Deferme

KINESITHERAPIE DEFERME & CO

Behind KINESITHERAPIE DEFERME & CO are Peter Tallieu and Pieter Deferme.

See the full network in the app

Directors

According to the 2025 annual accounts

Peter Tallieu

Administrator-manager

Pieter Deferme

Administrator-manager

Establishments

Establishment units

Physical locations of this company

Registered office

Esenplein(DE) 21 box 1

8600 Diksmuide

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0465.957.217
VAT number: BE 0465.957.217
Registered office: Esenplein(DE) 21 bus 1, 8600 Diksmuide
Names & denominations: KINESITHERAPIE DEFERME & CO
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 April 1999
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗